(Q42995240)

12 November 2017

title

Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong (English)

1 reference

12 November 2017

1 reference

1 reference

Man-Fung Yuen

1

1 reference

12 November 2017

Ching-Lung Lai

series ordinal

2

1 reference

12 November 2017

language of work or name

1 reference

1 January 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

49

1 reference

12 November 2017

issue

1-2

1 reference

12 November 2017

page(s)

96-98

1 reference

Classification of chronic hepatitis: diagnosis, grading and staging

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1159%2F000087270

Crossref

reference URL

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1159%2F000087270

Crossref

reference URL

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1159%2F000087270

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1159/000087270

1 reference

12 November 2017

1 reference